Chittorgarh.com Logo
Loading...

Gland Pharma IPO Subscription Details (Live Status)

Gland Pharma IPO Details

Issue Open Nov 9, 2020
Issue Close Nov 11, 2020
IPO Price ₹1500
Face Value ₹1
IPO Size ₹6,479.55 Cr
Listing At BSE, NSE
IPO Lot Size 10

Gland Pharma IPO Subscription Status Live

Gland Pharma IPO subscribed 2.06 times. The public issue subscribed 0.24 times in the retail category, 6.40 times in QIB, and 0.51 times in the NII category by Nov 11, 2020.

Investor CategorySubscription (times)
Qualified Institutions6.40
Non-Institutional Buyers0.51
Retail Investors0.24
Employees[.]
Others[.]
Total2.06

Gland Pharma IPO Subscription Details (times)

DateQIBNIIRetailTotal

Day 1
Nov 9, 2020

0.00

0.01

0.08

0.04

Day 2
Nov 10, 2020

0.48

0.03

0.15

0.22

Day 3
Nov 11, 2020

6.40

0.51

0.24

2.06


Gland Pharma IPO Shares Offered

Gland Pharma IPO is a public issue of 30,237,879 equity shares. The issue offers 15,118,939 shares to retail investors, 8,639,394 shares to qualified institutional buyers, and 6,479,546 shares to non-institutional investors.

CategoryShares Offered%
QIB8,639,39428.57%
NII6,479,54621.43%
Retail15,118,93950.00%
Total30,237,879100%

IPO Investor Categories

  • Qualified Institutional Buyers (QIB)

    Financial Institutions, Banks, FIIs, and Mutual Funds registered with SEBI are called QIBs. In most cases, QIBs represent small investors who invest through mutual funds, ULIP schemes of insurance companies, and pension schemes.

  • Non-Institutional Investors(NII)

    Individual investors, NRIs, companies, trusts, etc who bid for more than Rs 2 lakhs are known as Non-institutional bidders or NII. They need not register with SEBI like QIIs.

  • Retail Individual Investors(RII)

    The retail individual investor or NRIs who apply up to Rs 2,00,000 in an IPO are considered as RII reserved category.

  • Employee (EMP)

    A category of eligible employees who have a reserved quota in the IPO.

  • Others

    A category of eligible shareholders or other investors who have a reserved quota in the IPO.

Gland Pharma IPO Subscription FAQs

The Gland Pharma IPO is subscribed 2.06 by Nov 11, 2020.

Gland Pharma IPO Subscription

Investor CategorySubscription (times)
Qualified Institutional6.40
Non Institutional0.51
Retail Individual0.24
Employee Reservations[.]
Others[.]
Total Subscription2.06

Retail category of Gland Pharma IPO subscribed 0.24 times as of date Nov 11, 2020. The public issue closes on Nov 11, 2020 for bidding.

An investor can apply in Gland Pharma IPO online via bank (using ASBA) or the broker (using UPI). The Gland Pharma IPO shares are offered online only.

The Gland Pharma IPO is subscribed 2.06 by Nov 11, 2020.

The Gland Pharma IPO allotment status is expected on or around Nov 17, 2020. Visit Gland Pharma IPO allotment status to check.

The Gland Pharma IPO listing date is Friday, November 20, 2020. The equity share of Gland Pharma Limited will list on BSE, NSE.

Visit Gland Pharma IPO subscription status page for real-time bidding information about Gland Pharma IPO.

Gland Pharma IPO Timetable

IPO Opens OnNov 9, 2020
IPO Closes OnNov 11, 2020
Finalisation of Basis of AllotmentNov 17, 2020
Initiation of RefundsNov 18, 2020
Credit of Shares to Demat AccountNov 19, 2020
IPO Listing DateNov 20, 2020

1 Comments

1. syed asif  Nov 10, 2020 10:20
Your IPO application of GLAND for 20 qty at Rs 1500.0 has been cancelled successfully - Team Sharekhan.